Laboratory Testing Brings Clarity to Brucellosis - Scorecard - MDSpire

Laboratory Testing Brings Clarity to Brucellosis

  • February 5, 2026

  • 3 min

Share

Clinical Scorecard: Laboratory Testing Brings Clarity to Brucellosis

At a Glance

CategoryDetail
ConditionBrucellosis
Key MechanismsZoonotic infection affecting livestock and humans, primarily diagnosed through serologic tests.
Target PopulationLivestock (cattle, goats, sheep, pigs) and humans in endemic regions.
Care SettingLow-resource settings, primarily in slaughterhouses.

Key Highlights

  • B. abortus identified as the only circulating Brucella species in Cameroon.
  • Estimated prevalence of Brucella infection: 8.3% in cattle, 7.3% in goats.
  • Culture positivity rate of 0.8% in cattle; PCR increased detection rates.
  • Serologic tests require careful interpretation; RBT and iELISA improve specificity.
  • Genomic analysis indicates long-standing regional circulation of B. abortus.

Guideline-Based Recommendations

Diagnosis

  • Use a combination of serologic tests, culture, and molecular methods for accurate diagnosis.

Management

  • Implement screening protocols using RBT and iELISA for livestock.

Monitoring & Follow-up

  • Regularly assess prevalence and species identification through comprehensive testing.

Risks

  • Serologic tests cannot distinguish between Brucella species; low sensitivity of culture in chronic infections.

Patient & Prescribing Data

Livestock and humans in endemic areas.

Combination of diagnostic methods is crucial for effective management.

Clinical Best Practices

  • Combine serology with molecular or culture-based methods for accurate species identification.
  • Validate iELISA assays locally to establish appropriate cutoff values.

References

Original Source(s)

Related Content